Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF‐A and VEGF‐C
- 31 August 2005
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 130 (6) , 869-877
- https://doi.org/10.1111/j.1365-2141.2005.05695.x
Abstract
There is little information regarding the lymphangiogenesis of malignant lymphoma. In this study, we evaluated the lymphangiogenesis and angiogenesis in 44 lymph nodes of 39 malignant lymphomas and five non-reactive normal lymph nodes, based on the lymphatic vessel density (LVD) and microvessel density (MVD) calculated by the computer-assisted assessment of vessel density. The LVD of malignant lymphomas was significantly higher than that of non-reactive normal lymph nodes, irrespective of subtypes (P = 0.00077). On the contrary, there was no difference in MVD between malignant lymphomas and non-reactive normal lymph nodes, except for diffuse large B cell lymphomas, which had a significantly low value of MVD, in comparison with non-reactive normal lymph nodes (P = 0.009). We further examined the expression of vascular endothelial growth factor (VEGF)-C and VEGF-A, which function on lymphangiogenesis in lymph node samples. VEGF-C was expressed in 36 of 39 malignant lymphomas. All 39 of the malignant lymphoma samples expressed VEGF-A. Furthermore, the level of LVD and VEGF-A or VEGF-C was positively correlated. These findings suggest that lymphangiogenesis is actively developed in lymph nodes of malignant lymphomas and it may be induced by both VEGF-A and VEGF-C secreted from lymphoma cells.Keywords
This publication has 34 references indexed in Scilit:
- VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasisThe Journal of Experimental Medicine, 2005
- Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implicationsLeukemia, 2005
- Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expressionLaboratory Investigation, 2005
- Tumor lymphangiogenesis in head and neck squamous cell carcinomaCancer, 2004
- VEGF and myeloid leukemiasLeukemia Research, 2004
- Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative LesionsJournal of Clinical Endocrinology & Metabolism, 2004
- Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinomaCancer, 2003
- Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin–Reed–Sternberg cells in Hodgkin's diseaseThe Journal of Pathology, 2002
- Clinical significance of vascular endothelial growth factor‐C (VEGF‐C) in breast cancerBreast Cancer Research and Treatment, 2001
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997